Skip to main content
. Author manuscript; available in PMC: 2013 Dec 18.
Published in final edited form as: Nucl Med Biol. 2012 Apr 23;39(6):10.1016/j.nucmedbio.2012.02.004. doi: 10.1016/j.nucmedbio.2012.02.004

Table 2.

Comparison of values of model parameters descriptive of the uptake of 99mTc-Duramycin and 99mTc-C2A-GST in area-at-risk

Parameters 99mTc-Duramycin 99mTc-C2A-GST
V1 (ml g−1) 0.31 0.24
Bmax (nmol g−1) 0.13 0.05
ksa (ml nmol−1 min−1) 2.21 2.32
Plasma half life (min) 2.2 10.0

V1 and Bmax are normalized to mass of at-risk tissue. ksa is binding rate constant for 99mTc-Duramycin.